SciELO - Scientific Electronic Library Online

vol.18 número1Molecular techniques integrated to the entomological surveillance of Chagas disease vectors: Study of the secondary vector Triatoma sordida in the Eastern Region of ParaguayCRISPR/Cas system: precision genome editing índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados




  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO


Memorias del Instituto de Investigaciones en Ciencias de la Salud

versão On-line ISSN 1812-9528


BATTILANA-DHOEDT, José Alberto; CACERES-DE ITALIANO, Cristina; GOMEZ, Nancy  e  CENTURION, Osmar Antonio. Pathophysiology, epidemiological profile and therapeutic management in acute coronary syndrome. Mem. Inst. Investig. Cienc. Salud [online]. 2020, vol.18, n.1, pp.84-96. ISSN 1812-9528.

Cardiovascular diseases are still widely the leading cause of death in the world today. Ischemic heart disease leads to a significant burden of public health expenses, which is why it is important to know the prevalence, epidemiology, pathophysiology and the adequate diagnostic and therapeutic management of acute coronary syndrome (ACS). Recent findings indicate that the first steps in atherosclerosis are essentially inflammatory. A systemic inflammatory response often accompanies ACS, and the documentation of its presence has been widely recognized as an indicator of recurrent coronary events. Evidence based medicine strongly suggests the importance of the inflammatory etiology in ACS. The traditional coronary risk factors end in a common final passage that develops an inflammatory process in the arterial wall. Improved and adequate understanding of the influence of inflammatory processes in ACS can lead not only to a better use of currently available therapeutics but also to the development of new therapeutic tools. Undoubtedly the constant refinements in the different therapeutic strategies of the ACS, combined with the addition of scientific understanding in the proper use of inflammatory markers, new pharmacological agents and new techniques of percutaneous coronary intervention with newer stents and other intracoronary devices will clarify our doubts and improve our diagnostic and therapeutic management of acute coronary syndrome based on scientific evidence.

Palavras-chave : Acute coronary syndrome; troponin; myocardial infarction.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )